JENNIFER CHANDLER: Open Payments
NPI 1871905117 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 27 payments from 11 companies in 2025. Trend: 2023 $137 · 2024 $361 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $323 |
| Novo Nordisk Inc | 3 | $50 |
| Indivior Inc. | 1 | $29 |
| Seqirus USA Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, QULIPTA, SUBLOCADE, Flucelvax, TRELEGY ELLIPTA, UZEDY, GVOKE HYPOPEN, IMBRUVICA.
Industry payments across NC — which companies pay providers there.
